What are the latest advances in Dysautonomia / POTS?

The most promising recent advances in Dysautonomia / POTS research focus on identifying underlying autoimmune mechanisms, investigating the role of mast cell activation, and refining diagnostic biomarkers to better categorize patient subtypes.

Current Research Directions

Researchers are increasingly exploring the hypothesis that Dysautonomia / POTS may be an autoimmune condition in a significant subset of patients. Studies are investigating the presence of autoantibodies directed against G-protein coupled receptors, such as the adrenergic and muscarinic receptors. Additionally, there is growing interest in the link between Post-Acute Sequelae of SARS-CoV-2 (PASC) and the development of Dysautonomia / POTS, which has spurred a surge in global research interest and funding.

Clinical Trials and Diagnostic Tools

While there are currently no FDA-approved gene therapies for this condition, several clinical trials are evaluating repurposed medications, including immunomodulatory therapies like intravenous immunoglobulin (IVIG) and various mast cell stabilizers. Diagnostic research is currently focused on identifying circulating biomarkers that could differentiate between neuropathic, hyperadrenergic, and hypovolemic subtypes of Dysautonomia / POTS. Patients interested in participating in research can visit ClinicalTrials.gov and search for "Postural Orthostatic Tachycardia Syndrome" to view active, recruiting studies. It is important to note that clinical research timelines are inherently unpredictable, and most studies are in early phases.

Leading Efforts

Institutions such as the Mayo Clinic, Vanderbilt University’s Autonomic Dysfunction Center, and the Dysautonomia International foundation are leading the effort to standardize care and push for rigorous clinical trials. These groups are instrumental in fostering international collaboration to better understand the systemic nature of Dysautonomia / POTS. We remain optimistic, as the volume of high-quality peer-reviewed literature on this condition has increased significantly over the past five years.

Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• Dysautonomia International (dysautonomiainternational.org)


• NIH Genetic and Rare Diseases Information Center (GARD)


• National Library of Medicine - ClinicalTrials.gov